Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aethlon Medical, Inc.
Aethlon Medical submits Avian influenza treatment grant application
May 8th, 2006
Aethlon Medical, Inc., (AEMD) has submitted an Avian influenza-related grant application entitled, "Extracorporeal Treatment of H5N1 Bird Flu Viral Sepsis." The grant was submitted to the National Institutes of Health (NIH) to be directed to the National Institute of Allergy and Infectious Disease (NIAID) as a phase I Small Business Innovation Grant. The grant application discusses the deployment of the Aethlon Hemopurifier as a therapy to clear inflammatory cytokines, H5N1 Avian Flu virus and viral fragments that stimulate viral sepsis. Grant collaborators include Leo L.M. Poon, Assistant professor at the University of Hong Kong, Department of...
Source: Biotech Week (2006-05-08)
|
